Morning scan TOS:
PM move spot NXTD with s/o 15m and float 6m, mc of 21M. Got the earning news pm, already up 45 cents close to 1.90 hod. Previous major resistance seen at 2.89 prefer to start short before that around 2.50 and show sign of weakness.
CYTR my short last weak looking to reject $1 area and try short it again for a swing. More plays today will make this to slow come down. If gets to over 1 will need to find weakness point.
Market hours:
XXII came up on my screen, with a spike over $2 made a nice clear b/o over $2. Hod 2.07 couldn't hols drop back down under $2. Down trending now
CYTR grinding on made new hod, TC2000 brokerage no shorts to swing and is to scary. Aug 8 they will release ER, .
NOVN has 2 green days, will look at this for a swing short
"We have never generated revenue from product sales and have incurred net losses in each year since inception. As of December 31, 2016, we had an accumulated deficit $123.0 million. We incurred net losses of $59.7 million, $28.1 million and $11.4 in the years ended December 31, 2016, 2015 and 2014, respectively. We expect to continue to incur substantial losses in the future as we conduct our planned operating activities. We do not expect to generate revenue from product sales unless and until we obtain regulatory approval from the FDA for our clinical-stage product candidates. If we obtain regulatory approval for SB204 or any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. In addition, we expect that we will continue to incur substantial expenses as we continue clinical trials and preclinical studies for, and research and development of, our product candidates and maintain, expand and protect our intellectual property portfolio. "
Comments
Post a Comment